Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study
- 6 February 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 37 (2) , 554-559
- https://doi.org/10.1016/s0735-1097(00)01155-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Midodrine Hydrochloride in the Treatment of Vasovagal SyncopePacing and Clinical Electrophysiology, 1999
- Pharmacotherapy of Neurally Mediated SyncopeCirculation, 1999
- Management of vasovagal syncope.Journal of Cardiovascular Electrophysiology, 1999
- Effect of Etilefrine in Preventing Syncopal Recurrence in Patients With Vasovagal SyncopeCirculation, 1999
- The North American vasovagal pacemaker study (VPS)Journal of the American College of Cardiology, 1999
- Midodrine: a role in the management of neurocardiogenic syncopeHeart, 1998
- Usefulness of Transdermal Scopolamine for Vasovagal SyncopeThe American Journal of Cardiology, 1996
- Efficacy of Different Treatment Strategies for Neurocardiogenic SyncopePacing and Clinical Electrophysiology, 1995
- Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of etilefrine versus placeboJournal of the American College of Cardiology, 1995
- A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by heap-up tiltJournal of the American College of Cardiology, 1993